Aseptic Sampling Market by Type (Manual [Type (Traditional, Single-use), Product (Bags, Bottles, Syringes, Accessories)], Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO, CRO) – Global Forecast to 2025

2020-06-28
Price :
Published : Jun-2020
No. of Pages : 138

 “The aseptic sampling market is projected to grow at a CAGR of 12.4% during the forecast period (2020–2025).”

The global aseptic sampling market size is projected to reach USD 474 million by 2025 from USD 264 million in 2020, at a CAGR of 12.4%. The growth of this market is driven majorly by factors such as the increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and funding to support life sciences research activities. On the other hand, issues related to leachables and extractable from single-use products are restraining market growth.

“By type, the manual aseptic sampling segment is expected to grow at the highest CAGR during the forecast period.”

Based on type, the aseptic sampling market is segmented into manual aseptic sampling and automated aseptic sampling. The manual aseptic segment is expected to register the highest growth during the forecast period. Manual aseptic sampling has traditionally been used in pharmaceutical and biotechnology manufacturing. Also, manufacturers are reluctant to shift to automatic sampling, citing high costs and the need to train staff to handle automated sampling processes.

“By end-user, the biotechnology and pharmaceutical manufacturers segment dominated the aseptic sampling market in 2019.”

Based on end-user, the aseptic sampling market is segmented into biotechnology and pharmaceutical manufacturers, contract research and manufacturing organizations, R&D departments, and other end users.. The biotechnology and pharmaceutical manufacturers segment accounted for the largest share of the aseptic sampling market in 2019, primarily due to the increasing adoption of aseptic sampling in existing manufacturing facilities owing to advantages such as low capital cost and easy implementation.

Asia Pacific aseptic sampling market is expected to witness the highest growth during the forecast period.”

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the expanding biomanufacturing sector, increasing government support, developing R&D infrastructure, and the growing outsourcing of bioproduction processes to this region from North America and Europe.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1–29%, Tier 2–37%, and Tier 3–34%
  • By Designation: C-level–35%, Director-level–25%, and Others–40%
  • By Region: North America–35%, Europe–32%, Asia Pacific–22%, RoW-11%

The prominent players operating in the global aseptic sampling market include Sartorius Stedim Biotech (France), Merck Millipore (Germany), Danaher Corporation (US), and Thermo Fisher Scientific (US), Saint-Gobain (France), GEA Group (Germany), Avantor, Inc. (US), QualiTru Sampling Systems (US), Keofitt (Denmark), GEMÜ Group (US), W. L. Gore & Associates (US), Flownamics Analytical Instruments, Inc. (US), Lonza (Switzerland), and Trace Analytics (US).

Research Coverage:

The report analyzes the aseptic sampling market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a more significant share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the aseptic sampling market
  • Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the aseptic sampling market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global aseptic sampling market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of leading players in the aseptic sampling market
Filed in: Pharmaceutical
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Patient Engagement Solutions Market by Component (Hardware, Software, Services), Delivery Mode (On Premise, Cloud), End User (Provider, Payer), Applications (Home Health, Financial Health), Therapeutic Area – Analysis and Global Forecast to 2025

“The patient engagement solutions market is projected to grow at a CAGR of 10.1% due to the 5.2.1.1  Implementation of government regulations and initiatives to promote patient-centric care.” The global patient engagement solutions market is projected to reach USD 19.3 billion by 2025 from USD 11.9 billion in 2020, at a CAGR of 10.1% during the forecast period. The growth of this market is driven by the implementation of government regulations and initiatives to promote patient-centric care, increasing demand for patient engagement solutions, and the increasing utilization of mobile health apps. However, a lack of interoperability of PES and a dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.......
$4950

Radiation Dose Management Market by Products & Services (Standalone Solutions, Integrated Solutions, Services), Modality (Computed Tomography, Nuclear Medicine), Application (Oncology, Cardiology, Orthopedic), End User (Hospitals) – Global Forecast to 2025

“Radiation dose management market is projected to grow at CAGR of 13.9% from 2020 to 2025” The global radiation dose management market is projected to reach USD 422.65 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9% from 2020 to 2025. Growth in this market is driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management. On the other hand, the lack of standardized procedures and dose protocols for radiation dose management for healthcare organizations is a major market challenge. “Radiation dose management solutions segment to witness the highest growth during t......
$4950

Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer

Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer Summary When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions to curb these potential disasters. The COVID-19 Clinical and Commercial Analyzer is an interactive Excel-based tool that scores leading pipeline-stage vaccines and therapeutics on a range of clinical and commercial parameters based on available clinical data. The catalyst for the initial release of this analysis, dated August 10, 2020, includes all clinical data readouts and other market-altering events that have occurred since the outbreak's inception. With the constantly evolving COVID-19 outbreak, players need rapidly updated and detailed information on the potent......
$4995

United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others

United States In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others Summary GlobalData's "United States In Vitro Diagnostics Market Outlook to 2025" is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on - - Annualized market revenues (USD), volume (units) and average prices (USD) data for each of t......
$5995

HIV Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact)

HIV Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary HIV Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on HIV Tests market for the year 2020 and beyond. HIV is an ongoing, global public health issue that remains a major priority for most governments. HIV tests are performed for two purposes: i) screening and diagnosis; or ii) monitoring of HIV-positive patients, particularly those undergoing antiretroviral therapy (ART). Screening of pregnant women for HIV is standard of care in most countries and considered to be a cost-effective st......
$7500

South Korea Healthcare, Regulatory and Reimbursement Landscape – CountryFocus

South Korea Healthcare, Regulatory and Reimbursement Landscape - CountryFocus Summary GlobalData, the industry analysis specialist, has released its latest report, "South Korea Healthcare, Regulatory and Reimbursement Landscape - CountryFocus". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in South Korea. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house an......
$1995

Taiwan Healthcare, Regulatory and Reimbursement Landscape – CountryFocus

Taiwan Healthcare, Regulatory and Reimbursement Landscape - CountryFocus Summary GlobalData, the industry analysis specialist, has released its latest report, "Taiwan Healthcare, Regulatory and Reimbursement Landscape - CountryFocus". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Taiwan. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the Taiwan. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house an......
$1995

Coronavirus Disease 2019 (COVID-19) – Epidemiology Analysis and Forecast (July 2020 Edition)

Coronavirus Disease 2019 (COVID-19) - Epidemiology Analysis and Forecast (July 2020 Edition) Summary Globally, the total confirmed cases of COVID-19 have reached over 17 million with over 667,000 deaths and 9,964,000 recoveries. The US continues to be the most affected country globally, with over 4.4 million cases. The US fell to ranking seventh globally in terms of per capita daily incident rates, however, the US is still ranked number one in terms of total daily incidence. South Africa reported over 7,200 new confirmed cases of COVID-19 yesterday and over 7,000 new confirmed cases of COVID-19 on Tuesday. These are the two lowest daily incident rates reported by South Africa since the beginning of July, however, South Africa still remains as ranking fourth in total daily incident rat......
$1995

Opioid Use Disorder – Opportunity Analysis and Forecasts to 2028

Opioid Use Disorder: Opportunity Analysis and Forecasts to 2028 Summary Opioids are synthetic or natural agents that stimulate opioid receptors in the brain and nervous system. Opioids are often used to treat patients suffering from pain. When taken in the prescribed quantities, opioids do not generally lead to addiction. Opioid use disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, compulsive use of opioid drugs, and prolonged self-administration of opioid drugs. As the brain adapts to a prolonged opioid use, the patient's tolerance increases, so a higher dose of opioid is needed to stimulate the mesolimbic system in the same way as the original dose, leading patients to use continued higher doses of the drug. There are two ......
$10995

Opioid Use Disorder – Epidemiology Forecast to 2028

Opioid Use Disorder - Epidemiology Forecast to 2028 Summary Opioid use disorder (OUD) is defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) as a problematic pattern of opioid use leading to clinically significant impairment or distress. Symptoms of OUD include strong desire for opioids, inability to control or reduce use, continued use despite interference in major obligations or social functioning, use of larger amounts over time, development of tolerance, spending a great deal of time to obtain and use opioids, and withdrawal symptoms that occur after stopping or reducing use such as negative mood, nausea or vomiting, muscle aches, diarrhea, fever, and insomnia (American Psychiatric Association, 2013). GlobalData epidemiologists utilized histor......
$3995
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy